Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion

Paclitaxel, a new antitubular agent, appears to be one of the most promising single agents for the chemotherapy of various solid tumors. The primary objectives of this phase I study of paclitaxel using 24‐h continuous intravenous infusions were to determine the maximum tolerated dose of paclitaxel a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Jpn J Cancer Res
Hoofdauteurs: Tamura, Tomohide, Sasaki, Yasutsuna, Eguchi, Kenji, Shinkai, Tetsu, Ohe, Yuichiro, Nishio, Makoto, Kunikane, Hiroshi, Arioka, Hitoshi, Karato, Atsuya, Omatsu, Hironobu, Nakashima, Hajime, Saijo, Nagahiro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Publishing Ltd 1994
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919347/
https://ncbi.nlm.nih.gov/pubmed/7961108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1994.tb02906.x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items